Meet researcher Elaine Mardis of the Institute for Genomic Medicine at Nationwide Children’s Hospital in Ohio and coauthor of a feature article on cancer vaccines.

The three-dimensional cell cultures are still in the development phase, but researchers are excited about their use to predict patients’ responses to various treatment options.

The Howard University surgeon was the first African American president of the American Cancer Society and mentored thousands of medical students.

As ONC201 moves through human clinical trials, scientists finally figure out that the compound and its analogs target a mitochondrial protease.

Machine learning can analyze photographs of cancer, tumor pathology slides, and genomes. Now, scientists are poised to integrate that information into cancer uber-models.

An early-stage clinical study finds that none of the 25 patients treated developed neurotoxicity or cytokine release syndrome, common hazards of the cancer immunotherapy.

Breast cancer researcher and oncologist Nancy Davidson discusses what we’ve learned from the first wave of epigenetic trials for breast cancer, and what challenges lie ahead before such therapies reach the clinic.

Researchers describe ways to study how cancer cells evade therapies that harness the immune system.

Researchers found that allegedly noncoding genetic material carries the instructions for many peptides that may help harness the immune system to fight cancer.